To facilitate academic collaborations with industry, EATRIS provides research services geared towards biotech SMEs and pharmaceutical companies such as:
• Molecular imaging studies for drug (target) evaluation and biodistribution
• Preclinical and clinical PET/CT, PET/MRI and (ultra) high field MRI imaging
• Ex-vivo, organoid, PDX and animal models (including non-human primates)
• Access to clinical samples and biobanks, rare patient cohorts
• Scientific/medical experts and KOLs, rare patient populations
• Development and validation of in vitro assays
• Cell tracking, immuno-monitoring
• Biomarker validation: NGS, deep genome sequencing, mass spec and multi-omics analysis
• Regulatory advice for the development of advanced therapies (ATMP) and repurposing and Orphan Drug Designation